Medulloblastoma Comprises Four Distinct Molecular VariantsPaul A. Northcott, Michael D. Taylor, Andrey Korshunov et al.|Journal of Clinical Oncology|2010Cited by 1.4k
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair DeficiencyÉric Bouffet, Uri Tabori, Peter B. Dirks et al.|Journal of Clinical Oncology|2016Cited by 867
Medulloblastoma exome sequencing uncovers subtype-specific somatic mutationsTrevor J. Pugh, Yoon‐Jae Cho, Shyamal Dilhan Weeraratne et al.|Nature|2012Cited by 770
Risk stratification of childhood medulloblastoma in the molecular era: the current consensusVijay Ramaswamy, Scott L. Pomeroy, Marc Remke et al.|Acta Neuropathologica|2016Cited by 650
Epigenomic alterations define lethal CIMP-positive ependymomas of infancyStephen C. Mack, Sérgio L. Pereira, Michael D. Taylor et al.|Nature|2014Cited by 621